Compare Nuvalent Inc (NUVL) vs SAP SE (SAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs SAP SE — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while SAP SE trades at $154.29 (market cap $183.83B). The key difference: SAP SE is far larger — about 18.7× Nuvalent Inc's market cap, and SAP SE pays a 1.85% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | SAP | |
|---|---|---|
Market Cap | $9.81B | $183.83B |
Sector | Technology | Technology |
52-Week High | $123.96 | $307.27 |
52-Week Low | $72.16 | $148.06 |
Enterprise Value | $8.52B | $181.35B |
Dividend Yield | — | 1.85% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About SAP SE
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.
Read more on SAP →
